on 15 Jan 2019
Last Applicant/ Owned by
Northern Ireland Science Park
Belfast Co. Antrim BT3 9DT
GB
Serial Number
79221183 filed on 27th Oct 2017
Registration Number
5651894 registered on 15th Jan 2019
Correspondent Address
Helen Hill Minsker
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Chemicals and chemical preparations for use in industry, science and research; Biochemical substances and biochemical preparations for use in industry, science and research, namely, excipients for use in the manufacture of pharmaceutical preparations, cosmetic preparations, nutraceutical preparations, veterinary preparations, dietary supplements, foods and pharmaceutical preparations for topical u Read More
Antiviral pharmaceutical preparations, anti-infective pharmaceutical preparations, anti-inflammatory pharmaceutical preparations, antiseptic pharmaceutical preparations, antibacterial pharmaceutical preparations, antibiotic pharmaceutical preparations, antifungal pharmaceutical preparations, and anti-fibrotic pharmaceutical preparations; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders, musculoskeletal diseases and disorders, inflammatory diseases and disorders, respiratory diseases and disorders, pulmonary diseases and disorders, immune system related diseases and disorders, hematological diseases and disorders, oncological diseases and disorders, urological diseases and disorders, gastro-intestinal diseases, eye diseases and conditions, heart rhythm disorders, kidney diseases, nephropathic diseases, hematological disorders, diabetes, hypertension, skin disorders, damaged skin and tissue, wrinkles, wounds and allergies, insect bites, dermatological diseases and disorders, HIV, cancer and tumors, bone diseases, arthritis, cardiopulmonary diseases and disorders, infectious diseases, blood disorders, pain, sepsis, alopecia, obesity, cognitive disorders and diseases, neurological disorders, hormonal disorders, disorders of the autoimmune system, metabolic system diseases and disorders, endocrine system diseases and disorders, genitourinary system diseases and disorders; Preparations in the nature of animal feed supplements containing trace elements; Preparations in the nature of human vaccine preparations containing trace elements; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, nutraceutical and veterinary products; Drug delivery agents consisting of nanoparticle compounds that facilitate delivery of a wide range of pharmaceutical, nutraceutical and veterinary products; Drug delivery agents consisting of silicon compounds that facilitate delivery of a wide range of pharmaceutical, nutraceutical and veterinary products; Drug delivery agents consisting of porous silicon compounds that facilitate delivery of a wide range of pharmaceutical, nutraceutical and veterinary products; drug delivery agents consisting of compounds for facilitating the delivery of chemical, biochemical, biological, and pharmaceutical vaccines; Drug delivery agents consisting of compounds containing silicon-based nanoparticles for facilitating the delivery of chemical, biochemical, biological, and pharmaceutical vaccines; Drug delivery agents consisting of compounds containing silicon-based porous nanoparticles for facilitating the delivery of chemical, biochemical, biological, and pharmaceutical vaccines; Drug delivery agents consisting of compounds for facilitating the delivery of chemical, biochemical, biological, and pharmaceutical antibiotics; drug delivery agents consisting of compounds containing silicon-based nanoparticles for facilitating the delivery of chemical, biochemical, biological, and pharmaceutical antibiotics; drug delivery agents consisting of compounds containing silicon-based porous nanoparticles for facilitating the delivery of chemical, biochemical, biological, and pharmaceutical antibiotics; Chemical, biochemical, biological and pharmaceutical substances for medicinal use being pharmaceutical preparation stabilizers
Chemicals and chemical preparations for use in industry, science and research; Biochemical substances and biochemical preparations for use in industry, science and research, namely, excipients for use in the manufacture of pharmaceutical preparations, cosmetic preparations, nutraceutical preparations, veterinary preparations, dietary supplements, foods and pharmaceutical preparations for topical use; Chemical preparations for pharmaceutical, medical and veterinary research in the nature of reagents and substrates, namely, chemical compounds for use in patterning at nano scale or near nano scale; Silicon for use in industry, science and research; Silicon nanoparticle materials, namely, silicon and silicon-based chemical compounds for use in industry, science and research; Porous silicon nanoparticle materials, namely, silicon and silicon-based chemical compounds for use in industry, science and research; Chemical materials, namely, chemical catalysts for carrying and delivery of chemical, biochemical and biological substances for use in industry and not for medical or veterinary use; Silicon for use in stabilising enzymes of chemical, biochemical and biological substances for scientific research purposes; Nanoparticle materials, namely, silicon-based chemical compounds for use in stabilising enzymes of chemical, biochemical and biological substances for scientific research purposes; Silicon nanoparticle materials being silicon-based chemical compounds for use in stabilising enzymes of chemical, biochemical and biological substances for scientific research purposes; Porous silicon nanoparticle materials being silicon-based chemical compounds for stabilising enzymes of chemical, biochemical and biological substances for use in industry and for scientific research purposes; Chemicals and chemical preparations, namely, reagents and catalysts for pharmaceutical research purposes; Chemicals and chemical preparations, namely, reagents and catalysts for scientific research in the field of medicine, veterinary and pharmaceutics; Excipient for use in the manufacture of pharmaceutical products, including for the manufacture of vaccines and veterinary preparations
No 79221183
No Service/Collective Mark
No 008814.00006
No
No
No
No
Yes
Yes
No
No
Status Date | Action Taken |
---|---|
15th Jan 2024 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
17th May 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
01st May 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
30th Apr 2019 | FINAL DISPOSITION PROCESSED |
15th Apr 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
15th Jan 2019 | REGISTERED-PRINCIPAL REGISTER |
14th Dec 2018 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
30th Oct 2018 | PUBLISHED FOR OPPOSITION |
30th Oct 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
26th Oct 2018 | NOTIFICATION PROCESSED BY IB |